Literature DB >> 23737697

Spontaneous regression of metastatic melanoma after inoculation with tetanus-diphtheria-pertussis vaccine.

T Tran1, D Burt, L Eapen, O R Keller.   

Abstract

Spontaneous regression of metastatic melanoma is an exceedingly rare event, with only 76 well-documented cases in the literature since 1866. Here, we present the case of a patient who developed metastatic melanoma despite interferon therapy and who then achieved spontaneous regression shortly after a reaction to tetanus-diphtheria-pertussis vaccination. A common theme among these cases is the development of febrile illness before remission of the malignant disease. A brief overview of proposed mechanisms for these miraculous recoveries is presented, including a highlight on the potential role of the herv-k-mel viral marker, a nona- or decapeptide that appears in most melanomas, with homologies to peptides in pathogenic microorganisms.

Entities:  

Keywords:  Melanoma; cancer; diphtheria; fever; pertussis; regression; tetanus; vaccination

Year:  2013        PMID: 23737697      PMCID: PMC3671034          DOI: 10.3747/co.20.1212

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  20 in total

1.  TRANSPLACENTAL METASTASIS OF MALIGNANT MELANOMA. REPORT OF A CASE.

Authors:  B CAVELL
Journal:  Acta Paediatr Suppl       Date:  1963

2.  Spontaneous regression of a malignant melanoma.

Authors:  V B LEVISON
Journal:  Br Med J       Date:  1955-02-19

3.  Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control.

Authors:  Bernd Krone; Klaus F Kölmel; Beate M Henz; John M Grange
Journal:  Eur J Cancer       Date:  2005-01       Impact factor: 9.162

4.  Malignant Melanoma: A Study of 217 Cases: Part I: Epidemiology.

Authors:  G E Block; S W Hartwell
Journal:  Ann Surg       Date:  1961-12       Impact factor: 12.969

Review 5.  An innate sense of danger.

Authors:  P Matzinger
Journal:  Semin Immunol       Date:  1998-10       Impact factor: 11.130

6.  The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus).

Authors:  W B Coley
Journal:  Proc R Soc Med       Date:  1910

7.  Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone.

Authors:  M H Samore; G R Siber
Journal:  Vaccine       Date:  1996-03       Impact factor: 3.641

Review 8.  Bacteria and their toxins tamed for immunotherapy.

Authors:  Irena Adkins; Jana Holubova; Martina Kosova; Lenka Sadilkova
Journal:  Curr Pharm Biotechnol       Date:  2012-06       Impact factor: 2.837

Review 9.  Spontaneous regression of metastases from melanoma: review of the literature.

Authors:  Louise Vennegaard Kalialis; Krzysztof T Drzewiecki; Helle Klyver
Journal:  Melanoma Res       Date:  2009-10       Impact factor: 3.599

10.  A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes.

Authors:  Francesca Schiavetti; Joëlle Thonnard; Didier Colau; Thierry Boon; Pierre G Coulie
Journal:  Cancer Res       Date:  2002-10-01       Impact factor: 12.701

View more
  13 in total

1.  Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.

Authors:  Phyu P Aung; Priyadharsini Nagarajan; Victor G Prieto
Journal:  Lab Invest       Date:  2017-02-27       Impact factor: 5.662

2.  Spontaneous regression of pancreatic cancer with liver metastases.

Authors:  Patricia Saade Lemus; Kevin Anderson; Martin Smith; Andrea Bullock
Journal:  BMJ Case Rep       Date:  2019-05-31

Review 3.  Regulatory considerations for clinical development of cancer vaccines.

Authors:  Bridget Theresa Heelan
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Congenital solitary reticulohistiocytosis (Hashimoto - Pritzker).

Authors:  Luciana Prates Nogueira de Lima; Carolina Viza Amorim; Rachel Martins Marinho; Maria Letícia Cintra; Elemir Macedo de Souza
Journal:  An Bras Dermatol       Date:  2022-09-21       Impact factor: 2.113

5.  Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse Events.

Authors:  Cameron J Oswalt; Rami N Al-Rohil; Bala Theivanthiran; Tarek Haykal; April K S Salama; Nicholas C DeVito; Alisha Holtzhausen; Dennis C Ko; Brent A Hanks
Journal:  J Immunother       Date:  2022-05-30       Impact factor: 4.912

6.  Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.

Authors:  David Escors
Journal:  New J Sci       Date:  2014-01-05

Review 7.  Repurposing Infectious Diseases Vaccines Against Cancer.

Authors:  Liese Vandeborne; Pan Pantziarka; An M T Van Nuffel; Gauthier Bouche
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

Review 8.  The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies.

Authors:  Bernd Krone; Klaus F Kölmel; John M Grange
Journal:  BMC Cancer       Date:  2014-08-16       Impact factor: 4.430

9.  Changes in Immunogenicity during the Development of Urinary Bladder Cancer: A Preliminary Study.

Authors:  Wojciech Jóźwicki; Anna A Brożyna; Jerzy Siekiera; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2016-02-25       Impact factor: 5.923

Review 10.  Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?

Authors:  David Escors; Therese Liechtenstein; Noemi Perez-Janices; Julia Schwarze; Ines Dufait; Cleo Goyvaerts; Alessio Lanna; Frederick Arce; Idoia Blanco-Luquin; Grazyna Kochan; David Guerrero-Setas; Karine Breckpot
Journal:  Oncoimmunology       Date:  2013-09-12       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.